Skip to content

Non-PVC Fluid Path Port Access Infusion Set With Slit Septum Injection Site

by Kawasumi Laboratories Co., Ltd.

510(k) K964117

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK964117 Date14 Mar 1997ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
LJT
Device Class
Class II
Regulation
21 CFR Part 880.5965
Advisory Committee
General Hospital
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 26 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Non-PVC Fluid Path Port Access Infusion Set is a medical device designed to access implanted medication ports. It facilitates the delivery of medications into the patient's system via an intravascular route.

This device is classified as an implanted, subcutaneous, intravascular port and catheter under FDA regulation number 880.5965. It has received FDA 510(k) clearance for use in general hospital settings.

Other devices from Kawasumi Laboratories Co., Ltd.

See all devices from Kawasumi Laboratories Co., Ltd. →

Questions

AI-generated answers, 26 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the primary purpose of this infusion set?

    This device is designed to access implanted medication ports, allowing for the delivery of medications into a patient's system via an intravascular route.

  • What regulatory classification does this device fall under?

    This device is classified as an implanted, subcutaneous, intravascular port and catheter under FDA regulation number 880.5965 and has received FDA 510(k) clearance for use in general hospital settings.

  • What are the key features of this infusion set?

    The set features a non-PVC fluid path and includes a slit septum injection site, which is specifically engineered to facilitate reliable access to implanted ports.